Other Clinical Trial - Uterus Transplantation by Robotics

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03277430` - Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study	Phase 3
Completed	`NCT03581019` - Uterus Transplantation From Deceased Donor - Gothenburg III	N/A
Completed	`NCT03138226` - Living Donor Uterus Transplantation Between Identical Twins

See also

Status

Clinical Trial

Phase

Recruiting

NCT03277430 - Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study

Phase 3

Completed

NCT03581019 - Uterus Transplantation From Deceased Donor - Gothenburg III

N/A

Completed

NCT03138226 - Living Donor Uterus Transplantation Between Identical Twins

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05089513
Study type	Interventional
Source	Sahlgrenska University Hospital, Sweden
Contact	Mats Brännström, MD, PhD
Phone	+46736254455
Email	mats.brannstrom@obgyn.gu.se
Status	Recruiting
Phase	N/A
Start date	October 21, 2021
Completion date	August 30, 2024

Uterus Transplantation by Robotics - Gothenburg III — Robot2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms